SMTE-001

N/A

Report date: 2026/03/19 17:18:19

Base Information

Drug NameSMTE-001

Drug Alias NameSMTE-001

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAnti-CD3Anti-Mesothelin

TargetsT cell surface glycoprotein CD3Mesothelin

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSimcere Pharmaceutical Group Ltd

China Registration ClassN/A

Develop Information

Active CompaniesSimcere Pharmaceutical Group Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A